Hoesseini Arta, Dronkers Emilie A C, Dieleman Eveline, De Herdt Maria J, Wieringa Marjan H, van Velthuysen Marie-Louise F, Offerman Marinella P J, Sewnaik Aniel, Monserez Dominiek, Keereweer Stijn, Hardillo Jose A U, de Jong Robert Jan Baatenburg
Department of Otorhinolaryngology and Head and Neck Surgery, Erasmus MC Cancer Institute, Erasmus University Medical Center, Dr. Molewaterplein 40, Rotterdam, 3015 GD, The Netherlands.
Department of Otorhinolaryngology and Head and Neck Surgery, Leiden University Medical Centre, Leiden, The Netherlands.
BMC Cancer. 2025 Apr 25;25(1):778. doi: 10.1186/s12885-025-14100-4.
BACKGROUND: Every year, almost 900.000 people are diagnosed with head and neck cancer (HNC) worldwide. HNC contains many different subsites and a large variability in tumor biology. This often results in small and/or heterogeneous study populations. Developing overarching databases is an efficient solution to collect and analyze data of these smaller subsets of patients and to facilitate data sharing among research groups. The few existing large databases often include only basic characteristics. In addition, hospital-based cohorts that include more variables are often not collected consecutively, resulting in selection bias. Therefore, we established a hospital-based cancer registry system "Rotterdam Oncology Documentation" (RONCDOC), a complete and consecutive data warehouse and tissue collection for HNC, directly registered at the source. The primary aim of this paper is to report on our data collection protocol in order to make the RONCDOC data accessible and reusable for other researchers, and to offer a blue print to other consortia planning to establish their own data warehouse. METHODS: Data collected in the Netherlands Cancer Registry (NCR) of patients with HNC were obtained from the Netherlands comprehensive cancer organization (IKNL) and merged with corresponding data from the electronic patient file (EPF). The data were manually verified using the EPF, and enriched with additional variables from the EPF according to an extensive data entry protocol. Furthermore, a comprehensive validation protocol was developed to guarantee the quality of the data. Tissue microarrays (TMAs) were constructed from resection specimens of patients with primary oral squamous cell carcinoma. CONCLUSION: With RONCDOC, we have established a consecutive and high-quality data warehouse for HNC. This paper outlines the essential steps for establishing such a data warehouse, offering a blueprint for other consortia. TRIAL REGISTRATION: This study was approved by the ethics committee of the Erasmus Medical Center (MEC-2016-751).
Cochrane Database Syst Rev. 2021-4-19
Cochrane Database Syst Rev. 2020-1-9
Cochrane Database Syst Rev. 2016-8-26
Cochrane Database Syst Rev. 2017-12-22
Cochrane Database Syst Rev. 2022-5-20
Cochrane Database Syst Rev. 2022-5-23
Cochrane Database Syst Rev. 2022-10-4
BMC Palliat Care. 2024-2-24
Otolaryngol Head Neck Surg. 2018-8-21
Acta Oncol. 2017-12-11